Abstract
Until April 2021, WHO declared more than 140 million cases and 3 million deaths due to COVID-19. To effectively control the pandemic, a significant part of the population has to acquire immunity, which is best achieved through vaccination. None of the clinical trials evaluating the effectiveness and safety of the vaccines included cancer patients. This study aimed to evaluate the acceptance of the COVID-19 vaccine by cancer patients undergoing immunosuppressive therapy in a Portuguese cancer centre.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call